CD274 and metastatic neoplasm: Considering disease status, the percentage of CTCs expressing the phenotype PD-L1+CD45−CK+ in early vs. metastatic disease was 70% vs. 91%, respectively, whereas the percentage of PD-L1-negative CTCs was 30% vs. 9% (p = 0.049), respectively.